Author
By Alexandra Slessarev Recent headlines highlighted a $40 million investment by a range of Blue Cross Blue Shield companies in Solera Health, a start-up focused on improving chronic disease management. Solera Health will use the investment…
A series of failures among devices designed for women’s health has invigorated the FDA’s focus on its post-market regime.
People with developmental disabilities are often less able to care for their teeth, and sometimes require special services not offered during routine care.
A number of state-level legislative projects are generating excitement about Medicaid buy-in plans.
While more research in this area is needed, studies show that paid leave can and should be framed as a public health issue, and that the health costs of not providing paid leave should be…
Questions about “filth” in food illuminate how complex our relationship to food is, and how difficult it can be to balance the imperative to inform the public with other health policy goals.
By Alexandra Slessarev In early October, the Department of Homeland Security published a proposed redefinition of the Immigrant and Nationality Act’s “public charge” provision, stirring serious concern among health-care and immigrant advocacy groups. The “public…
By Alexandra Slessarev As Nicholas Terry wrote in his recent blog post, the 2018 midterm elections produced some big wins for Medicaid. Voters in Idaho, Nebraska and Utah decided to expand Medicaid coverage under the ACA.…
By Alexandra Slessarev At the end of last month, the New York Times reported on a leaked internal memorandum from Health and Human Services proposing to narrowly define “sex” as “biological sex,” a move made…
By Alexandra Slessarev At the end of September, the Senate passed a final version of an expansive legislative package designed to tackle the United States opioid epidemic. The package contains a broad range of policy approaches…
